Insulet
NASDAQ: PODDActon, US · 5,430 employees on LinkedIn · 2 known investors
Find your way into Insulet
Insulet develops the Omnipod, a tubeless, wearable, disposable insulin delivery Pod, along with automated insulin delivery systems for people managing insulin-dependent diabetes. Its products serve people with diabetes and their caregivers in the medical device and diabetes management category.
Founders & leadership
AA
Ashley A. McEvoyinPresident & Chief Executive OfficerAshley McEvoy is the President and Chief Executive Officer of Insulet Corporation, a medical device company that develops insulin delivery systems for diabetes management. She previously held multiple executive leadership roles at Johnson & Johnson across its MedTech division and business units from 1996 to 2023, and is a graduate of the University of Pennsylvania.
FP
Flavia PeaseinChief Financial OfficerFlavia Pease is Executive Vice President and Chief Financial Officer at Insulet, which develops wearable insulin delivery systems for people managing insulin-dependent diabetes. She brings 25 years of finance management experience, including expertise in mergers and acquisitions and operations across US and emerging markets.
EB
Eric BenjamininChief Operating OfficerHe previously held positions in R&D, manufacturing, and quality at Abbott Laboratories, and holds degrees in industrial engineering from UC Berkeley, bioengineering from UC San Diego, and an MBA from Harvard Business School.
LB
Lisa Blair DavisinSenior Vice President, Chief Human Resources OfficerSenior Vice President of Human Resources at Insulet, which develops insulin delivery systems and automated diabetes management solutions.
MH
Michael H. PanosExecutive Vice President, Chief Commercial Officer
Investors · 2
Competitors · 2
by search overlap
DexCom90 shared keywordsDexcom develops continuous glucose monitoring (CGM) systems and glucose biosensors, including the Dexcom G7 and the over-the-counter Stelo biosensor, that send real-time glucose readings to a phone or receiver. Its products serve people managing diabetes as well as consumers tracking glucose for general health, diet, and exercise.
Diabetes63 shared keywordsA nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.
Companies competing with Insulet for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Insulet (PODD) Stock Slumps As Earnings Beat Collides With Guidance Reset - StocksToTradestockstotrade.com · Aug 2026Frequently asked questions
- What does Insulet do?
- Insulet develops the Omnipod, a tubeless, wearable, disposable insulin delivery Pod, along with automated insulin delivery systems for people managing insulin-dependent diabetes. Its products serve people with diabetes and their caregivers in the medical device and diabetes management category.
- Who are Insulet's investors?
- Insulet's investors include SV Health Investors, Winklevoss Capital.
- Where is Insulet headquartered?
- Insulet is headquartered in Acton, US.